Type V and VI CRISPR/Cas systems have emerged as promising cutting-edge diagnostic tools for nucleic acid detection. Nevertheless, the challenge of low target concentrations necessitates ...
The accurate and timely detection of disease biomarkers at the point-of-care is essential to ensure effective treatment and prevention of diseases. CRISPR-based diagnostics (CRISPR-Dx) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback